Institut des Neurosciences Cellulaires et Intégratives-INCI CNRS-UPR 3212, 5 rue Blaise Pascal, 67084 Strasbourg, France.
Institut de Génomique Fonctionnelle, CNRS UMR 5203, INSERM U1191, Université de Montpellier, LabEx 'Ion Channel Science and Therapeutics', 141 rue de la Cardonille, 34094 Montpellier, France.
Neurobiol Dis. 2017 Oct;106:110-123. doi: 10.1016/j.nbd.2017.07.004. Epub 2017 Jul 5.
Episodic Ataxia type 2 (EA2) is an autosomal dominant neuronal disorder linked to mutations in the Ca2.1 subunit of P/Q-type calcium channels. In vitro studies have established that EA2 mutations induce loss of channel activity and that EA2 mutants can exert a dominant negative effect, suppressing normal Ca2.1 activity through protein misfolding and trafficking defects. To date, the role of this mechanism in the disease pathogenesis is unknown because no animal model exists. To address this issue, we have generated a mouse bearing the R1497X nonsense mutation in Ca2.1 (Ca2.1). Phenotypic analysis of heterozygous Ca2.1 mice revealed ataxia associated with muscle weakness and generalized absence epilepsy. Electrophysiological studies of the cerebellar circuits in heterozygous Ca2.1 mice highlighted severe dysregulations in synaptic transmission of the two major excitatory inputs as well as alteration of the spontaneous activity of Purkinje cells. Moreover, these neuronal dysfunctions were associated with a strong suppression of Ca2.1 channel expression in the cerebellum of heterozygous Ca2.1 mice. Finally, the presence of Ca2.1 in cerebellar lipid raft microdomains was strongly impaired in heterozygous Ca2.1 mice. Altogether, these results reveal a pathogenic mechanism for EA2 based on a dominant negative activity of mutant channels.
发作性共济失调 2 型(EA2)是一种常染色体显性神经元疾病,与 P/Q 型钙通道的 Ca2.1 亚基的突变有关。体外研究已经证实,EA2 突变会导致通道活性丧失,而 EA2 突变体可以通过蛋白质错误折叠和运输缺陷发挥显性负效应,抑制正常的 Ca2.1 活性。迄今为止,由于没有动物模型,这种机制在疾病发病机制中的作用尚不清楚。为了解决这个问题,我们已经生成了一种携带 Ca2.1 中的 R1497X 无义突变的小鼠(Ca2.1)。杂合 Ca2.1 小鼠的表型分析显示出与肌肉无力和全身性失神性癫痫相关的共济失调。杂合 Ca2.1 小鼠小脑回路的电生理研究强调了两个主要兴奋性输入的突触传递的严重失调,以及浦肯野细胞自发性活动的改变。此外,这些神经元功能障碍与小脑 Ca2.1 通道表达的强烈抑制有关。最后,杂合 Ca2.1 小鼠小脑脂筏微区中 Ca2.1 的存在受到严重损害。总之,这些结果揭示了一种基于突变通道显性负活性的 EA2 致病机制。